SK
Highly rated in
5
conditions
Highly rated in
5
conditions
Check Dr. Steven C. Kirshblum's experience treating your condition:
About Dr. Steven C. Kirshblum

Steven Kirshblum is a Physiatrist in West Orange, New Jersey. Kirshblum has been practicing medicine for over 36 years and is highly rated in 5 conditions, according to our data. His top areas of expertise are Paraplegia, Autonomic Dysreflexia, Neurogenic Bowel, and Spasticity. He is licensed to treat patients in New Jersey. Kirshblum is currently accepting new patients.

His clinical research consists of co-authoring 138 peer reviewed articles and participating in 9 clinical trials in the past 15 years.

Areas of Expertise

Many experts have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions aexpert treats and their level of experience.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Steven C. Kirshblum it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Steven C. Kirshblum accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
1199 Pleasant Valley Way, West Orange, NJ 07052
Other Locations
1199 Pleasant Valley Way, West Orange, NJ 07052
Background & Education
Graduate Institution
R Franklin University Of Med & Sci/chicago Medical School, 1986.0
Specialties
Physiatry
Licenses
Spinal Cord Injury Medicine in NJ
Hospital Affiliations
Cooperman Barnabas Medical Center
Kessler Institute For Rehabilitation - West Orange
Languages Spoken
English
Vietnamese
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

The Efficacy of Denosumab to Prevent Bone Loss in Ambulatory and Non-ambulatory Motor-Incomplete Patients With Subacute Spinal Cord Injury
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
Treatment With Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
The Effect of Whole Body Vibration on Spasticity in Spinal Cord Injury Patients
The Efficacy of Denosumab to Reduce Osteoporosis After Spinal Cord Injury
Prevention of Long-Term Respiratory Complications of Spinal Cord Injury: a Randomized Controlled Trial
Restoring Lost Functions After Spinal Cord Injury: Combination Therapy With Dalfampridine and Locomotor Training for Persons With Chronic, Motor Incomplete Spinal Cord Injury
View 5 Less Clinical Trials -

136 Total Publications

Incomplete spinal cord syndromes: Current incidence and quantifiable criteria for classification.
Summary: Incomplete spinal cord syndromes: Current incidence and quantifiable criteria for classification.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors